NorthAvenue LLC’s Colgate-Palmolive CL Stock Holding History

NorthAvenue LLC’s Portfolio CL Stock Details CL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-13	Closed	-$1.03K	–	290
2025 Q4	$1.03K	Buy	+13	New	+$1.02K	﹤0.01%	207

Other funds holding CL

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

DAM

Diamant Asset Management Ridgefield, Connecticut $137B AUM 18.02% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

NorthAvenue LLC's CL Position: Q1 2026 in Review

NorthAvenue LLC sold out of Colgate-Palmolive (CL) in Q1 2026, closing a stake of 13 shares — an estimated $1.03K sold.

NorthAvenue LLC first reported a position in CL in Q4 2025 and held it in 1 quarter. The position peaked at $1.03K in Q4 2025. 1,947 funds tracked by Wall St. Rank hold CL as of Q1 2026.

NorthAvenue LLC reported no remaining Colgate-Palmolive position as of Q1 2026 after selling out during the quarter.
NorthAvenue LLC sold 13 Colgate-Palmolive shares in Q1 2026, an estimated $1.03K.
NorthAvenue LLC first reported a position in Colgate-Palmolive in Q4 2025 and held it in 1 quarter.
NorthAvenue LLC's Colgate-Palmolive position peaked at $1.03K in Q4 2025.
1,947 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q1 2026.

Based on NorthAvenue LLC's 13F filing for Q1 2026, filed 15 Apr 2026.